A 52-year-old man from Delhi presents with a 3-month history of persistent cough and weight loss. Chest X-ray shows a cavitary lesion in the right upper lobe. A rapid diagnostic test for tuberculosis (GeneXpert MTB/RIF) is performed and returns negative. The patient is clinically highly suspicious for pulmonary TB. What is the most appropriate next step in management?

Explanation

## Clinical Context The patient has a classic TB presentation (cavitary lesion in the right upper lobe, persistent cough, weight loss) in a high-burden setting (Delhi), but a negative GeneXpert MTB/RIF. This scenario tests understanding of test sensitivity and the appropriate diagnostic algorithm when a high-sensitivity test returns negative in a high-pretest-probability case. ## Why Sputum Smear Microscopy is the Next Step **Key Point:** GeneXpert MTB/RIF has high sensitivity (~95%) for smear-positive TB but lower sensitivity (~70–80%) for smear-negative TB. A single negative GeneXpert does NOT exclude TB in a clinically suspicious case. **High-Yield:** The WHO and Indian NTEP (National TB Elimination Programme) guidelines recommend sputum smear microscopy (Ziehl-Neelsen or fluorescence staining) as the next diagnostic step when GeneXpert is negative but clinical suspicion remains high. At least 2 sputum samples must be examined to increase detection probability, as TB bacilli are shed intermittently. ## Diagnostic Algorithm ```mermaid flowchart TD A[Clinical suspicion of TB]:::outcome --> B[Perform GeneXpert MTB/RIF]:::action B --> C{Result positive?}:::decision C -->|Yes| D[Confirm TB diagnosis]:::outcome C -->|No| E{High clinical suspicion?}:::decision E -->|No| F[Observe, repeat if symptoms persist]:::action E -->|Yes| G[Sputum smear microscopy × 2 samples]:::action G --> H{Smear positive?}:::decision H -->|Yes| I[Start anti-TB therapy]:::action H -->|No| J[Culture, LJ medium or MGIT]:::action J --> K{Culture positive?}:::decision K -->|Yes| L[Confirm TB, start therapy]:::outcome K -->|No| M[Reconsider diagnosis]:::outcome ``` ## Why This Approach? 1. **Sensitivity consideration:** GeneXpert can miss paucibacillary disease; smear microscopy remains a rapid, widely available tool for case detection in resource-limited settings. 2. **Multiple samples:** 2–3 samples increase detection probability due to intermittent bacillary shedding. 3. **Guideline-aligned:** Indian NTEP and WHO recommend this stepwise approach before escalating to culture or empirical therapy. **Clinical Pearl:** A negative GeneXpert in a cavitary TB case is unusual but not impossible—paucibacillary disease, prior partial treatment, or technical factors may explain it. Smear microscopy provides rapid additional microbiological evidence without significant delay. **Note on Option A (Repeat GeneXpert):** While repeating GeneXpert on a fresh sample is a reasonable consideration, NTEP guidelines specifically recommend proceeding to sputum smear microscopy (rather than a second GeneXpert) as the next step when the first GeneXpert is negative in a high-suspicion case, making Option C the more guideline-concordant answer. **Note on Option B (Empirical therapy):** NTEP guidelines do permit initiation of empirical anti-TB therapy in high-suspicion cases when microbiological confirmation is delayed or unavailable; however, the preferred approach is to first attempt additional microbiological confirmation (smear microscopy, then culture) before starting treatment, to avoid treating non-TB conditions and to document baseline drug susceptibility. *Reference: WHO Consolidated Guidelines on Tuberculosis, Module 3 (2022); NTEP Technical and Operational Guidelines for TB Control in India (2016, updated 2022); Harrison's Principles of Internal Medicine, 21st ed.*